- Cholesterol absorption and insulinoresistancePublication without faculty affiliation
- Inhibitors of cholesterol absorptionPublication without faculty affiliation
- The humic substances influence on cholesterol absorption +1Publication without faculty affiliation
- Ezetimib - the selective inhibitor of cholesterol absorption2004 | First Faculty of Medicine
- Products influencing cholesterol absorption - benefit and riskPublication without faculty affiliation
- Cholesterol absorption and biosynthesis after hypolipidemic intervention by LDL-apheresisPublication without faculty affiliation
- Cholesterol absorption - mechanism, metabolic sequels, pharmacological and dietary influencesPublication without faculty affiliation
- Cholesterol absorption and biosynthesis of hypercholesterolemic subjects treated by LDL-apheresisPublication without faculty affiliation
- Endothelial dysfunction in type 2 diabetes mellitus is associated with decreased cholesterol absorption and increased cholesterol synthesisPublication without faculty affiliation
- Ezetimib - new type of combination therapy of hypercholesterolemia2004 | Second Faculty of Medicine
- Cholesterol homeostasis and cardiovascular risk2011 | First Faculty of Medicine
- Stereoselective Synthesis of Ezetimibe via Cross-Metathesis of Homoallylalcohols and alpha-Methylidene-beta-Lactams2016 | Faculty of Science
- Associations of Serum Uric Acid with Endogenous Cholesterol Synthesis Indices in Men with High Cardiometabolic Risk2020 | First Faculty of Medicine
- Omentin-1 plasma levels and cholesterol metabolism in obese patients with diabetes mellitus typ 1: impact of weight reduction2015 | Faculty of Medicine in Hradec Králové
- Dual inhibition - a new perspective of the treatment of hypercholesterolaemia2003 | First Faculty of Medicine
- Dual inhibition - new trend in the treatment of dyslipidemias2003 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The vegetable sterols in diabetics2004 | First Faculty of Medicine
- Clinical and pathophysiological impact of noncholesterol sterols2004 | First Faculty of Medicine
- Intensive reduction of LDL cholesterol and ezetimibe for the treatment of evidence2009 | First Faculty of Medicine
- Metabolism of cholesterol in obese patients with diabetes mellitus type 1 - impact of weight reduction2015 | Faculty of Medicine in Hradec Králové
- Association of noncholesterol sterols with cardiometabolic risk factors2018 | First Faculty of Medicine
- Zoletorv - Pharmacological profile2017 | Faculty of Medicine in Pilsen
- Combination of statin and ezetimibe: most often in only one pill and for more patients2021 | First Faculty of Medicine
- Lipid-lowering drugs and their indication in patients with chronic kidney disease2015 | First Faculty of Medicine
- Lipid-lowering drugs in patients with chronic kidney disease2016 | First Faculty of Medicine
- Low concentration of plasma cholesterol and type 2. diabetes mellitus2021 | First Faculty of Medicine
- The significance of noncholester sterols as novel risk factors for cardiovascular diseases2013 | First Faculty of Medicine
- Non-cholesterol sterols and fatty acids in hemodialysed patients2017 | First Faculty of Medicine, Central Library of Charles University
- A Matched Case-Control Study of Noncholesterol Sterols and Fatty Acids in Chronic Hemodialysis Patients2021 | First Faculty of Medicine, Third Faculty of Medicine